Andy (ChengYao) Ko is a seasoned professional in the pharmaceutical and biotechnology industries with extensive experience in various strategic and managerial roles. Currently serving as the Business Unit Head for Specialty Care in The Philippines at Merck Group since April 2016, Andy has previously held positions such as Associate Director of ONC Franchise Strategy and PMO in China and APAC Regional Associate Marketing Director for Cardiovascular Metabolic Disease in Singapore. Andy's career also includes a global growth assignment in the Oncology Business Franchise at Merck KGaA, as well as roles at Roche and Bristol-Myers Squibb. Andy holds an International Full-time MBA from the Rotterdam School of Management, Erasmus University, focusing on Finance, and a Master's degree in Biotechnology from National Cheng Kung University.
This person is not in any teams
This person is not in any offices